Published in Curr Pharm Des on March 01, 2000
Mechanism and fidelity of HIV reverse transcriptase. J Biol Chem (1992) 4.57
Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors. Science (1995) 3.60
Weak binding of VX-478 to human plasma proteins and implications for anti-human immunodeficiency virus therapy. J Infect Dis (1995) 2.42
Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase. J Biol Chem (2001) 2.31
Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc Natl Acad Sci U S A (1993) 2.16
Mechanistic studies examining the efficiency and fidelity of DNA synthesis by the 3TC-resistant mutant (184V) of HIV-1 reverse transcriptase. Biochemistry (1999) 1.45
Insights into the molecular mechanism of mitochondrial toxicity by AIDS drugs. J Biol Chem (2001) 1.31
Mechanistic studies comparing the incorporation of (+) and (-) isomers of 3TCTP by HIV-1 reverse transcriptase. Biochemistry (1999) 1.30
Structure and topological symmetry of the glyphosate target 5-enolpyruvylshikimate-3-phosphate synthase: a distinctive protein fold. Proc Natl Acad Sci U S A (1991) 1.29
Y265H mutator mutant of DNA polymerase beta. Proper teometric alignment is critical for fidelity. J Biol Chem (2001) 1.27
Tissue-specific induction of murine glutathione transferase mRNAs by butylated hydroxyanisole. J Biol Chem (1988) 1.27
Mechanism of action of 1-beta-D-2,6-diaminopurine dioxolane, a prodrug of the human immunodeficiency virus type 1 inhibitor 1-beta-D-dioxolane guanosine. Antimicrob Agents Chemother (2001) 1.17
Pre-steady-state kinetic analysis of the trichodiene synthase reaction pathway. Biochemistry (1997) 1.15
Detection and characterization of a phospholactoyl-enzyme adduct in the reaction catalyzed by UDP-N-acetylglucosamine enolpyruvoyl transferase, MurZ. Biochemistry (1994) 1.13
Surface point mutations that significantly alter the structure and stability of a protein's denatured state. Protein Sci (1996) 1.09
Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model. Antimicrob Agents Chemother (1994) 1.08
HIV-1 reverse transcriptase resistance to nonnucleoside inhibitors. Biochemistry (1996) 1.06
Loop closure and intersubunit communication in tryptophan synthase. Biochemistry (1998) 1.05
Mechanism of inhibition of the human immunodeficiency virus type 1 reverse transcriptase by d4TTP: an equivalent incorporation efficiency relative to the natural substrate dTTP. Antimicrob Agents Chemother (2000) 1.03
Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase. Clin Cancer Res (2001) 1.02
RNA dependent DNA replication fidelity of HIV-1 reverse transcriptase: evidence of discrimination between DNA and RNA substrates. Biochemistry (1997) 1.02
Mechanistic studies show that (-)-FTC-TP is a better inhibitor of HIV-1 reverse transcriptase than 3TC-TP. FASEB J (1999) 1.00
Substrate channeling and domain-domain interactions in bifunctional thymidylate synthase-dihydrofolate reductase. Biochemistry (1998) 0.99
Structural and functional characterization of the HPV16 E7 protein expressed in bacteria. J Biol Chem (1993) 0.99
Crosslinking of substrates occurs exclusively to the p66 subunit of heterodimeric HIV-1 reverse transcriptase. Biochem Biophys Res Commun (1991) 0.98
Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals. Cancer Res (2001) 0.97
DNA polymerase activity of hepatitis B virus particles: differential inhibition by L-enantiomers of nucleotide analogs. Antiviral Res (1996) 0.94
Leishmania major pteridine reductase 1 belongs to the short chain dehydrogenase family: stereochemical and kinetic evidence. Biochemistry (1998) 0.92
Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus. Antimicrob Agents Chemother (1993) 0.92
Intersubunit communication in tryptophan synthase by carbon-13 and fluorine-19 REDOR NMR. Biochemistry (1996) 0.91
Using loop length variants to dissect the folding pathway of a four-helix-bundle protein. J Mol Biol (1999) 0.91
Generalized measurable ignition criterion for inertial confinement fusion. Phys Rev Lett (2010) 0.90
Detection and identification of transient enzyme intermediates using rapid mixing, pulsed-flow electrospray mass spectrometry. Biochemistry (1997) 0.90
Speeding up protein folding: mutations that increase the rate at which Rop folds and unfolds by over four orders of magnitude. Fold Des (1997) 0.89
Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn's colitis. Aliment Pharmacol Ther (2014) 0.89
Conformational changes induced in herpes simplex virus DNA polymerase upon DNA binding. Proc Natl Acad Sci U S A (1993) 0.88
Initiation of minus-strand DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase. Biochemistry (1999) 0.87
Insights into the HER-2 receptor tyrosine kinase mechanism and substrate specificity using a transient kinetic analysis. Biochemistry (2000) 0.87
Linking genomics to immunotherapy by reverse immunology--'immunomics' in the new millennium. Curr Mol Med (2001) 0.85
Mechanistic studies to understand the inhibition of wild type and mutant HIV-1 reverse transcriptase by Carbovir-triphosphate. Nucleosides Nucleotides Nucleic Acids (2001) 0.85
Dynamic aspects of ionophore mediated membrane transport. Top Curr Chem (1982) 0.85
Reevaluating glyphosate as a transition-state inhibitor of EPSP synthase: identification of an EPSP synthase.EPSP.glyphosate ternary complex. Biochemistry (1995) 0.85
Rare naturally occurring immune responses to three epitopes from the widely expressed tumour antigens hTERT and CYP1B1 in multiple myeloma patients. Clin Exp Immunol (2005) 0.85
Catalytic mechanism of Kdo8P synthase: transient kinetic studies and evaluation of a putative reaction intermediate. Biochemistry (1998) 0.85
Crystallographic studies of phosphonate-based alpha-reaction transition-state analogues complexed to tryptophan synthase. Biochemistry (1999) 0.84
Duration of Alphavirus neutralizing antibody in naturally infected birds. Am J Trop Med Hyg (1988) 0.84
Implication of the tRNA initiation step for human immunodeficiency virus type 1 reverse transcriptase in the mechanism of 3'-azido-3'-deoxythymidine (AZT) resistance. Biochemistry (1998) 0.84
Identification of the nucleotide binding site of HIV-1 reverse transcriptase using dTTP as a photoaffinity label. Biochemistry (1993) 0.83
Expression of human cyclophilin-40 and the effect of the His141-->Trp mutation on catalysis and cyclosporin A binding. Eur J Biochem (1995) 0.83
Structure and functional relationships in human pur H. Adv Exp Med Biol (1998) 0.82
Structural and kinetic analysis of a channel-impaired mutant of tryptophan synthase. J Biol Chem (1994) 0.82
Energetics of S-adenosylmethionine synthetase catalysis. Biochemistry (2000) 0.81
Antagonism of prostaglandin-mediated responses in platelets and vascular smooth muscle by 13-azaprostanoic acid analogs. Evidence for selective blockade of thromboxane A2 responses. Biochem Pharmacol (1985) 0.81
Recombinant human immunodeficiency virus type 1 reverse transcriptase is heterogeneous. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.81
Kinetic reaction scheme for the dihydrofolate reductase domain of the bifunctional thymidylate synthase-dihydrofolate reductase from Leishmania major. Biochemistry (1998) 0.80
Deoxythioguanosine triphosphate impairs HIV replication: a new mechanism for an old drug. FASEB J (2001) 0.79
Equilibrium cation binding selectivity of the carboxylic ionophore narasin A: a comparison with transport selectivities reported in two biological test systems. Biochem Pharmacol (1986) 0.79
Role of desolvation energy in the nonfacilitated membrane permeability of dideoxyribose analogs of thymidine. Mol Pharmacol (1992) 0.79
Investigation of the stereochemical course of DNA synthesis catalysed by human immunodeficiency virus type 1 reverse transcriptase. Biochem Biophys Res Commun (1989) 0.78
Safety assessment, in vitro and in vivo, and pharmacokinetics of emivirine, a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1. Antimicrob Agents Chemother (2000) 0.78
Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens. Vox Sang (2001) 0.78
Conformational dynamics of the carboxylic ionophore lasalocid A underlying cation complexation-decomplexation and membrane transport. Biochemistry (1982) 0.76
The role of molecular conformation in ion capture by carboxylic ionophores: a circular dichroism study of narasin A in single-phase solvents and liposomes. Biochim Biophys Acta (1986) 0.76
Carrier-independent entry of 1-methyl-4-phenylpyridinium (MPP+) into adrenal chromaffin cells as a consequence of charge delocalization. Biochem Biophys Res Commun (1990) 0.75
ECT seizure classification. Can J Anaesth (1998) 0.75
Transport and expression of class I MHC glycoproteins in an antigen-processing mutant cell line. Cold Spring Harb Symp Quant Biol (1992) 0.75
The effects of lipid composition on the binding of lasalocid A to small unilamellar vesicles. Biochim Biophys Acta (1990) 0.75
A review of succinylcholine-induced apnea. AANA J (1982) 0.75
High-rhoR implosions for fast-ignition fuel assembly. Phys Rev Lett (2007) 0.75
Shock ignition of thermonuclear fuel with high areal density. Phys Rev Lett (2007) 0.75
A Logarithmic Complexity Floating Frame of Reference Formulation with Interpolating Splines for Articulated Multi-Flexible-Body Dynamics. Int J Non Linear Mech (2013) 0.75
Accumulation of 1-methyl-4-phenylpyridinium (MPP+) into bovine chromaffin granules results in a large restriction of its molecular motion: a 13C and 31P NMR study. Biochem Biophys Res Commun (1988) 0.75
The catalytic mechanism of EPSP synthase revisited. Biochemistry (1999) 0.75
Operative treatment of congenital pseudarthrosis of the tibia. Acta Orthop Scand (1974) 0.75
Conformational requirements of alpha 2-adrenergic receptors. Mol Pharmacol (1982) 0.75